S. 4793 aims to clarify how tariffs are applied to goods in U.S. foreign-trade zones, specifically in relation to the United States-Mexico-Canada Agreement (USMCA) and the Foreign Trade Zones Act. The bill seeks to ensure that the tariff treatment of merchandise in these zones is consistent and clear, potentially impacting how businesses operate within these trade zones.
Supporters of S. 4793 argue that the bill will enhance clarity and efficiency for businesses operating in foreign-trade zones, which could lead to increased trade and economic growth. They believe that by streamlining tariff regulations, the bill will help U.S. companies remain competitive in the global market.
Critics of S. 4793 express concerns that the bill may favor large corporations at the expense of smaller businesses, potentially leading to an uneven playing field. Additionally, some argue that the bill could complicate existing trade agreements or lead to unintended consequences in tariff collections.
The analysis of bill S. 4793, which pertains to tariff treatment in foreign-trade zones, reveals no direct overlaps between the sponsor Tim Scott's top donor industries and the bill's subject matter. The top donor industries do not appear to have a vested interest in the specifics of trade agreements or tariff regulations. While there is lobbying activity in related areas, such as from Altria Client Services and the American College of Clinical Pharmacy, these entities do not directly correlate with the bill's focus on trade and tariffs. The total lobbying contributions from these organizations amount to $234,981, but they do not indicate a direct conflict with the bill's provisions. Therefore, the potential for conflicts of interest is low, as the financial interests of the donors do not align with the legislative intent of the bill.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AMERICAN COLLEGE OF CLINICAL PHARMACY | AMERICAN COLLEGE OF CLINICAL PHARMACY | $144,981 |
| ALTRIA CLIENT SERVICES | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $40,000 |
| CROHN'S & COLITIS FOUNDATION | CROHN'S & COLITIS FOUNDATION | $40,000 |
| GOTRIANGLE | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $30,000 |
| AFRICAN AMERICAN ALLIANCE OF CDFI CEOS | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | $20,000 |
| BRISTOL MYERS SQUIBB | ALEXANDER J. BECKLES, L.L.C. | $20,000 |
| CITY OF GLADEWATER, TEXAS | LONE STAR CONSULTING, LLC | $12,000 |
| CITY OF CRANDALL, TEXAS | LONE STAR CONSULTING, LLC | $10,000 |
| NATIONAL SLEEP FOUNDATION | SLEEP, INC. | undisclosed |
| SLEEP, INC. | SLEEP, INC. | undisclosed |
| THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES | MAGILL ASSOCIATES, LLC | undisclosed |
| OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| LUMBEE TRIBE HOLDINGS, INC. | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | undisclosed |
| CITY OF CLEVELAND, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
| CITY OF RIO HONDO, TEXAS | LONE STAR CONSULTING, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Tim Scott, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
